Aghion, P., Van Reenen, J., & Zingales, L. (2013). Innovation and institutional ownership. American economic review, 103(1), 277-304.
Angrist, J. D., & Pischke, J.-S. (2009). Mostly harmless econometrics: An empiricist’s companion. Princeton: Princeton University Press.
AntoÃŒÂn, M., Ederer, F., GineÃŒÂ, M., & Schmalz, M. C. (2017). Innovation: The bright side of common ownership? Appel, I. R., Gormley, T. A., & Keim, D. B. (2016). Passive investors, not passive owners. Journal of Financial Economics, 121(1), 111-141.
AntoÃŒÂn, M., Ederer, F., GineÃŒÂ, M., & Schmalz, M. C. (2018). Common ownership, competition, and top management incentives. Mimeo.
Appelt, S. (2015). Authorized generic entry prior to patent expiry: reassessing incentives for independent generic entry. Review of Economics and Statistics, 97(3 ), 654-666.
Azar, J. (2017). Portfolio Diversification, Market Power and the Theory of the Firm. IESE Business School, Universidad de Navarra. Working Paper.
- Azar, J., Raina, S., & Schmalz, M. C. (2016). Ultimate ownership and bank competition.
Paper not yet in RePEc: Add citation now
Azar, J., Schmalz, M. &Tecu, I. (2018). Anti-competitive effects of common ownership. Journal of Finance, forthcoming.
- Banal-Estanol, A., Seldeslachts, J. & Vives, X. (2018). Common Ownership - Product Market Consequences of a Shift from Active to Passive Investors. Mimeo.
Paper not yet in RePEc: Add citation now
Bena, J., Ferreira, M. A., Matos, P., & Pires, P. (2017). Are foreign investors locusts? The long-term effects of foreign institutional ownership. Journal of Financial Economics, 126(1), 122-146.
Berger, A. N., Hasan, I., & Zhou, M. (2010). The effects of focus versus diversification on bank performance: Evidence from Chinese banks. Journal of Banking & Finance, 34(7), 1417-1435.
Boone, A.L. & White, J.T. (2015). The effect of institutional ownership on firm transparency and information production.Journal of Financial Economics, 117(3), 508-533.
- Booraem, G. (2013). Passive investors, not passive owners: A look at Vanguard’s approach to proxy voting and corporate governance.
Paper not yet in RePEc: Add citation now
Branstetter, L., Chatterjee, C., & Higgins, M. J. (2016). Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry. The RAND Journal of Economics, 47(4), 857-890.
Brav, A., Jiang, W., Ma, S., & Tian, X. (2016). How does hedge fund activism reshape corporate innovation? (No. w22273). National Bureau of Economic Research.
Brav, A., Jiang, W., Partnoy, F., & Thomas, R. (2008). Hedge fund activism, corporate governance, and firm performance. The Journal of Finance, 63(4), 1729-1775.
Brito, D., Cabral, L., & Vasconcelos, H. (2016). Competitive Effects of Partial Control in an Input Supplier.
Brito, D., Ribeiro, R., & Vasconcelos, H. (2014). Measuring unilateral effects in partial horizontal acquisitions. International Journal of Industrial Organization, 33, 22-36.
Carleton, W. T., Nelson, J. M., & Weisbach, M. S. (1998). The influence of institutions on corporate governance through private negotiations: Evidence from TIAA-CREF.
Caudill, S. B. (1988). Practitioners corner: An advantage of the linear probability model over probit or logit. Oxford Bulletin of Economics and Statistics, 50(4), 425-427.
Cici, G., Gibson, S., & Rosenfeld, C. M. (2015). Cross-company effects of common ownership: Dealings between borrowers and lenders with a common blockholder.
- Coffee, J. C. (1991). Liquidity versus control: The institutional investor as corporate monitor. Columbia law review, 91(6), 1277-1368.
Paper not yet in RePEc: Add citation now
Costa-Font, J., McGuire, A., & Varol, N. (2014). Price regulation and relative delays in generic drug adoption. Journal of health economics, 38, 1-9.
Del Guercio, D. & Hawkins, J. (1999). The motivation and impact of pension fund activism. Journal of financial economics, 52(3), 293-340.
- Elhauge, E. (2016). Horizontal Shareholding. Harvard Law Review, 129:1267.
Paper not yet in RePEc: Add citation now
Fichtner, J., Heemskerk, E. M., & Garcia-Bernardo, J. (2017). Hidden power of the Big Three? Passive index funds, re-concentration of corporate ownership, and new financial risk. Business and Politics, 19(2), 298-326.
- Freeman, K. (2016). The Effects of Common Ownership on Customer-Supplier Relationships.
Paper not yet in RePEc: Add citation now
- Geng H, Hau H, Lai S. (2017). Patent success, patent holdup, and the structure of property rights.
Paper not yet in RePEc: Add citation now
- Gilje, E., Gormley, T. A., & Levit, D. (2018). The rise of common ownership.
Paper not yet in RePEc: Add citation now
Gilo, D., Moshe, Y., & Spiegel, Y. (2006). Partial cross ownership and tacit collusion. The RAND Journal of Economics, 37(1), 81-99.
- Glowicka, E., Lorincz, S., Pesaresi, E., Romero, L. S., & Verouden, V. (2009). Generic entry in prescription medicines in the EU: main characteristics, determinants and effects. Brussels: European Commission.
Paper not yet in RePEc: Add citation now
- Gramlich, J., & Grundl, S. (2017). Testing for Competitive Effects of Common Ownership.
Paper not yet in RePEc: Add citation now
- Handelsblatt Global (2016). The Supposed Influence of Asset Managers.
Paper not yet in RePEc: Add citation now
Harford, J., Jenter, D., & Li, K. (2011). Institutional cross-holdings and their effect on acquisition decisions. Journal of Financial Economics, 99(1), 27-39.
He, J. J., & Huang, J. (2017). Product market competition in a world of crossownership: Evidence from institutional blockholdings. The Review of Financial Studies, 30(8), 2674-2718.
Hudson, J. (2000). Generic take-up in the pharmaceutical market following patent expiry: a multi-country study. International Review of Law and Economics, 20(2), 205-221.
Hurwitz, M. A., & Caves, R. E. (1988). Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals. The Journal of Law and Economics, 31(2), 299-320.
- Jacobo-Rubio, R., Turner, J., & Williams, J. (2017). The Distribution of Surplus in the US Pharmaceutical Industry: Evidence from Paragraph (iv) Patent Litigation Decisions.
Paper not yet in RePEc: Add citation now
- Kennedy, P., O’Brien, D. P., Song, M., & Waehrer, K. (2017). The Competitive Effects of Common Ownership: Economic Foundations and Empirical Evidence.
Paper not yet in RePEc: Add citation now
Kyle, M. K. (2006). The role of firm characteristics in pharmaceutical product launches. The RAND Journal of Economics, 37(3), 602-618.
- Lopez, A. L., & Vives, X. (2017). Cross-ownership, R&D spillovers, and antitrust policy.
Paper not yet in RePEc: Add citation now
Malenko, N., & Shen, Y. (2016). The role of proxy advisory firms: Evidence from a regression-discontinuity design. The Review of Financial Studies, 29(12), 3394-3427.
McCahery, J. A., Sautner, Z., & Starks, L. T. (2016). Behind the scenes: The corporate governance preferences of institutional investors. The Journal of Finance, 71(6), 2905-2932.
Moreno-Torres, I., Puig-Junoy, J., & Borrell, J. R. (2009). Generic entry into the regulated Spanish pharmaceutical market. Review of Industrial Organization, 34(4), 373-388.
- New York Times (2016). Rise of Institutional Investors Raises Questions of Collusion.
Paper not yet in RePEc: Add citation now
- O’Brien, D. P., & Salop, S. C. (1999). Competitive effects of partial ownership: Financial interest and corporate control. Antitrust Law Journal, 67, 559.
Paper not yet in RePEc: Add citation now
- O’Brien, D. P., & Waehrer, K. (2017). The Competitive Effects of Common Ownership: We Know Less Than We Think.
Paper not yet in RePEc: Add citation now
- OECD (2017). Policy Roundtable: Common ownership by institutional investors and its impact on competition.
Paper not yet in RePEc: Add citation now
- Posner, E. A., Scott Morton, F. M., & Weyl, E. G. (2017). A proposal to limit the anti-competitive power of institutional investors. Antitrust Law Journal, forthcoming.
Paper not yet in RePEc: Add citation now
Regan, T. L. (2008). Generic entry, price competition, and market segmentation in the prescription drug market. International Journal of Industrial Organization, 26(4), 930-948.
Reiffen, D., & Ward, M. R. (2005). Generic drug industry dynamics. The Review of Economics and Statistics, 87(1), 37-49.
Reynolds, R. J., & Snapp, B. R. (1986). The competitive effects of partial equity interests and joint ventures. International Journal of Industrial Organization, 4(2), 141-153.
- Rotemberg J. (1984). Financial transaction costs and industrial performance. Working Paper, Alfred P. Sloan School of Management.
Paper not yet in RePEc: Add citation now
Rubinstein, A. & Yaari M.E. (1983). The competitive stock market as cartel maker: Some examples. Suntory and Toyota International Centres for Economics and Related Disciplines, LSE Saha, A., Grabowski, H., Birnbaum, H., Greenberg, P., & Bizan, O. (2006). Generic competition in the US pharmaceutical industry. International Journal of the Economics of Business, 13(1), 15-38.
- Schmalz, M. (2015). How Passive Funds Prevent Competition.
Paper not yet in RePEc: Add citation now
Schmalz, M. C. (2018). Common Ownership Concentration and Corporate Conduct.
Schmidt, C., & Fahlenbrach, R. (2017). Do exogenous changes in passive institutional ownership affect corporate governance and firm value? Journal of Financial Economics, 124(2), 285-306.
Scott Morton, F. M. (1999). Entry decisions in the generic pharmaceutical industry. The Rand Journal of Economics, 421-440.
Scott Morton, F. M. (2000). Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry. International Journal of Industrial Organization, 18(7), 1085-1104 Scott Morton, F. M. (2002). Horizontal integration between brand and generic firms in the pharmaceutical industry. Journal of Economics & Management Strategy, 11(1), 135-168.
Seldeslachts, J., Newham, M., & Banal-Estanol, A. (2017). Common ownership of German companies. DIW Economic Bulletin 30.
- The Economist (2015). Mutual funds and airline competition: Who really owns the skies? Xie, J., & Gerakos, J. (2018). Institutional cross-holdings and generic entry in the pharmaceutical industry.
Paper not yet in RePEc: Add citation now